Skip to Main Content
Table 2.

ORs for the relationship between height and the risk of epithelial ovarian cancer by ovarian cancer type

Height (cm)Adjusted OR* (95% CI)
All cancers (n = 764)All invasive (n = 630)All borderline (n = 134)Invasive serous (n = 342)Invasive endometrioid (n = 148)Invasive mucinous (n = 48)Borderline serous (n = 61)Borderline mucinous (n = 62)
<160† 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
160-164 1.17 (0.91-1.52) 1.11 (0.84-1.46) 1.81 (1.08-3.05) 1.16 (0.83-1.60) 0.99 (0.62-1.57) 1.24 (0.60-2.58) 0.98 (0.50-1.92) 4.52 (1.82-11.18) 
165-169 0.84 (0.63-1.13) 0.87 (0.64-1.18) 0.89 (0.49-1.62) 0.75 (0.51-1.10) 1.12 (0.69-1.84) 0.47 (0.17-1.26) 0.49 (0.22-1.08) 2.10 (0.77-5.74) 
170-174 1.00 (0.69-1.45) 0.89 (0.60-1.32) 1.53 (0.80-2.91) 0.85 (0.53-1.37) 0.97 (0.48-1.93) 1.08 (0.40-2.90) 0.64 (0.26-1.59) 4.67 (1.68-12.96) 
≥175 1.24 (0.69-2.22) 1.28 (0.69-2.40) 1.26 (0.47-3.40) 1.41 (0.70-2.84) 0.86 (0.24-3.12) 0.87 (0.17-4.33) 0.26 (0.03-2.14) 5.27 (1.45-19.08) 
Ptrend 0.79 0.66 0.74 0.55 0.93 0.53 0.06 0.021 
Height (cm)Adjusted OR* (95% CI)
All cancers (n = 764)All invasive (n = 630)All borderline (n = 134)Invasive serous (n = 342)Invasive endometrioid (n = 148)Invasive mucinous (n = 48)Borderline serous (n = 61)Borderline mucinous (n = 62)
<160† 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
160-164 1.17 (0.91-1.52) 1.11 (0.84-1.46) 1.81 (1.08-3.05) 1.16 (0.83-1.60) 0.99 (0.62-1.57) 1.24 (0.60-2.58) 0.98 (0.50-1.92) 4.52 (1.82-11.18) 
165-169 0.84 (0.63-1.13) 0.87 (0.64-1.18) 0.89 (0.49-1.62) 0.75 (0.51-1.10) 1.12 (0.69-1.84) 0.47 (0.17-1.26) 0.49 (0.22-1.08) 2.10 (0.77-5.74) 
170-174 1.00 (0.69-1.45) 0.89 (0.60-1.32) 1.53 (0.80-2.91) 0.85 (0.53-1.37) 0.97 (0.48-1.93) 1.08 (0.40-2.90) 0.64 (0.26-1.59) 4.67 (1.68-12.96) 
≥175 1.24 (0.69-2.22) 1.28 (0.69-2.40) 1.26 (0.47-3.40) 1.41 (0.70-2.84) 0.86 (0.24-3.12) 0.87 (0.17-4.33) 0.26 (0.03-2.14) 5.27 (1.45-19.08) 
Ptrend 0.79 0.66 0.74 0.55 0.93 0.53 0.06 0.021 
*

Adjusted for age (in years), age at menarche (<12, 12, 13, ≥14), weight at age 20 (in kg, <50, 50-<55, 55-<60, ≥60), ever use of oral contraceptives (yes/no), and parity (0, 1-2, 3+).

†

Reference group.

View Large
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept